Walleye Trading’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Walleye Trading’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-4,500	Closed	-$42K	–	6157
2015 Q4	$42K	Sell	4,500 -2,400	-35%	-$20.1K	﹤0.01%	3991
2015 Q3	$48K	Buy	6,900 +2,700	+64%	+$23.1K	﹤0.01%	3538
2015 Q2	$41K	Sell	4,200 -300	-7%	-$2.73K	﹤0.01%	3613
2015 Q1	$40K	Buy	4,500 +2,200	+96%	+$17.5K	﹤0.01%	3222
2014 Q4	$21K	Buy	+2,300	New	+$18.6K	﹤0.01%	3670

Walleye Trading's SCLN Position: Q4 2017 in Review

Walleye Trading sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 56,521 shares — an estimated $633 sold.

Walleye Trading first reported a position in SCLN in Q4 2014 and held it in 8 quarters. The position peaked at $57K in Q4 2015. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

Walleye Trading reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
Walleye Trading sold 56,521 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $633.
Walleye Trading first reported a position in Sciclone Pharmaceuticals Inc in Q4 2014 and held it in 8 quarters.
Walleye Trading's Sciclone Pharmaceuticals Inc position peaked at $57K in Q4 2015.
0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Walleye Trading's 13F filing for Q4 2017, filed 14 Feb 2018.